<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:46:31Z</responseDate>
  <request identifier="oai:figshare.com:article/32626953" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32626953</identifier>
        <datestamp>2026-10-01T17:46:24Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>The discovery and bioactivity evaluation of a novel peptide, QUB-2652, from the skin secretion of the South American frog, Phyllomedusa palliata</dc:title>
          <dc:creator>Ziyi Dong (8938655)</dc:creator>
          <dc:subject>PUREID: 157905129</dc:subject>
          <dc:description>In recent years, the antibiotic resistance of bacteria has stimulated the development of new antibiotics. Antimicrobial peptides (AMPs) from amphibian skin secretions possess broad-spectrum antimicrobial activities through the mechanism that is unlikely to induce antibiotic resistance. Thus, AMPs are great candidates for new antibiotics. &lt;br&gt;In this study, the precursor-encoding cDNA sequence of QUB-2652 was identified in the skin secretion of Phyllomedusa palliata by ‘Shotgun’ cloning. Then, QUB-2652 was synthesised by solid phase peptide synthesis (SPPS) according to its translated putative mature peptide sequence. After authenticated by Matrix-assisted laser desorption/ionisation Time-of-flight mass spectrometry and purified by Reversed-phase high performance liquid chromatography, the pure QUB-2652 was finally subjected to some functional tests. &lt;br&gt;According to the BLAST analysis, QUB-2652 showed high sequence similarity with dermaseptins. Results of functional tests showed that QUB-2652 possessed prominent antimicrobial activities against E. coli, S. aureus and C. albicans with the minimum inhibitory concentrations of 2, 2 and 1 µM, respectively. QUB-2652 also showed strong anti-proliferative effects on NCI-H157, PC-3 and U251MG cell lines. Meanwhile, the haemolytic activity of QUB-2652 on horse erythrocytes was 3.6% at 1 µM and 10.6% at 2 µM.  &lt;br&gt;This study is expected to inspire further studies on peptides from frog skin secretions and provide useful clues for developing new peptide antibiotics and anticancer drugs.</dc:description>
          <dc:date>2026-10-01T17:46:24Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32626953.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/The_discovery_and_bioactivity_evaluation_of_a_novel_peptide_QUB-2652_from_the_skin_secretion_of_the_South_American_frog_Phyllomedusa_palliata/32626953</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
